Valuation: AngioDynamics, Inc.

Market Cap 500M 446M 410M 373M 700M 47.41B 713M 4.95B 1.95B 24.86B 1.88B 1.84B 78.29B P/E 2027 *
-17.6x
P/E 2028 * -28x
Enterprise Value 500M 446M 410M 373M 700M 47.41B 713M 4.95B 1.95B 24.86B 1.88B 1.84B 78.29B EV / Sales 2027 *
1.48x
EV / Sales 2028 * 1.41x
Free-Float
85.66%
Yield 2027 *
-
Yield 2028 * -
1 day+1.09%
1 week+8.78%
Current month-21.85%
1 month-22.05%
3 months-15.47%
6 months+12.13%
Current year-6.39%
1 week 11.05
Extreme 11.05
12.22
1 month 10.62
Extreme 10.62
15.88
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2016
Director of Finance/CFO 51 23/10/2019
Chief Tech/Sci/R&D Officer - 01/01/2017
Director TitleAgeSince
Chairman 65 29/04/2014
Director/Board Member 68 29/01/2007
Director/Board Member 62 01/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
7/30/26 A Sell

General Counsel

-23,370 0.0565%
7/22/26 A Exercice

Executive/Senior Manager

40,889 0.0990%
7/22/26 A Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+8.78%+2.74%+78.07% 500M
+1.99%-0.45%-19.63%+5.92% 174B
+3.19%+9.04%-19.14%+15.58% 114B
+3.83%+2.50%+0.79%+32.86% 114B
+1.93%+19.62%-44.05%+8.64% 89.64B
-0.57%+0.69%+2.94%+79.33% 64.96B
-0.47%+3.86%+15.10%+80.50% 56.09B
+3.13%+6.10%+6.03%-22.51% 52.94B
+2.40%+7.14%-11.04%+32.73% 43.6B
+3.43%+8.36%-4.02%-10.63% 32.77B
Average +1.87%+4.76%-7.03%+30.05% 74.25B
Weighted average by Cap. +1.92%+3.58%-11.73%+22.79%

Financials

2027 *2028 *
Net sales 338M 301M 277M 252M 473M 32.02B 481M 3.34B 1.32B 16.79B 1.27B 1.24B 52.87B 355M 316M 291M 265M 497M 33.65B 506M 3.52B 1.38B 17.65B 1.33B 1.3B 55.57B
Net income -28.86M -25.72M -23.66M -21.53M -40.39M -2.74B -41.12M -286M -112M -1.43B -108M -106M -4.52B -18.19M -16.21M -14.92M -13.57M -25.47M -1.72B -25.93M -180M -70.92M -905M -68.25M -66.82M -2.85B
Net Debt - -
Projected Income Statement - Annual - AngioDynamics, Inc.
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
22/10/26 $12.02 +1.09% 673,141
21/10/26 $11.89 +0.68% 725,279
20/10/26 $11.81 +3.69% 1,367,373
19/10/26 $11.39 +1.33% 875,917
16/10/26 $11.24 -2.94% 890,697
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - AngioDynamics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.89USD
Average target price
19.75USD
Spread / Average Target
+66.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AngioDynamics, Inc.
  1. Stock Market
  2. Stocks
  3. ANGO Stock